Bomze HM, Bulsara K, Iskandar BJ, Caroni P, Skene JHP (2001)
Spinal axon regeneration evoked by replacing two growth cone
proteins in adult neurons. Nat Neurosci 4:38 – 43.
Bradbury EJ, Moon LDF, Popat RJ, King VR, Bennett GS, Patel PN,
Fawcett JW, McMahon SB (2002) Chondroitinase ABC promotes
functional recovery after spinal cord injury. Nature 416:636 – 640.
Cai D, Shen Y, De Bellard ME, Tang S, Filbin MT (1999) Prior exposure to neurotrophins blocks inhibition of axonal regeneration by
MAG and myelin via a cAMP-dependent mechanism. Neuron
22:89 –101.
Chen MS, Huber AB, van der Haar ME, Frank M, Schnell L, Spillmann
AA, Christ R, Schwab ME (2000) Nogo-A is a myelin-associated
neurite outgrowth inhibitor and an antigen for monoclonal antibody
IN-1. Nature 403:434 – 439.
Crowe MJ, Bresnahan JC, Shuman SL, Masters JN, Beattie MS
(1997) Apoptosis and delayed degeneration after spinal cord injury
in rats and monkeys. Nat Med 3:73–76.
Dahl D, Rueger DC, Bignami A, Weber K, Osborn M (1981) Vimentin,
the 57 000 molecular weight protein of fibroblast filaments, is the
major cytoskeletal component in immature glia. Eur J Cell Biol
24:191–196.
Davies SJA, Fitch MT, Memberg SP, Hall AK, Raisman G, Silver J
(1997) Regeneration of adult axons in white matter tracts of the
central nervous system. Nature 390:680 – 683.
Eng LF (1988) Astrocytic responses to injury. In: Current issues in
neural regeneration research (Reier PJ et al., eds), pp 247–255.
New York: Alan R. Liss.
Fawcett JW, Keynes RJ (1990) Peripheral nerve regeneration. Annu
Rev Neurosci 13:43– 60.
Flower RJ, Rothwell NJ (1994) Lipocortin-1: cellular mechanisms and
clinical relevance. Trends Pharmacol Sci 15:71–76.
Fournier AE, GrandPre T, Strittmatter SM (2001) Identification of a
receptor mediating Nogo-66 inhibition of axonal regeneration. Na- ture 409:341–346.
GrandPre T, Nakamura F, Vartanian T, Strittmatter SM (2000) Identification of the Nogo inhibitor of axon regeneration as a reticulon
protein. Nature 403:439 – 444.
Henderson CE, Phillips HS, Pollock RA, Davies AM, Lemeulle C,
Armanini M, Simpson LC, Moffet B, Vandlen RA, Koliatsos VE,
Rosenthal A (1994) GDNF: A potent survival factor for motoneurons present in peripheral nerve and muscle. Science
266:1062–1064.
Hoke A, Cheng C, Zochodne DW (2000) Expression of glial cell
line-derived neurotrophic factor family of growth factors in peripheral nerve injury in rats. Neuroreport 11:1651–1654.
Houle J (1992) The structural integrity of glial scar tissue associated
with a chronic spinal cord lesion can be altered by transplanted
fetal spinal cord tissue. J Neurosci Res 31:120 –130.
Hu J, Fink D, Mata M (2002) Microarray analysis suggests the involvement of proteasomes, lysosomes, and matrix metalloproteinases
in the response of motor neurons to root avulsion. Eur J Neurosci
16:1409 –1416.
Iannotti C, Li H, Yan P, Lu X, Wirthlin L, Xu X-M (2003) Glial cell
line-derived neurotrophic factor-enriched bridging transplants promote propriospinal axonal regeneration and enhance myelination
after spinal cord injury. Exp Neurol 183:379 –393.
Jing S, Wen D, Yu Y, Holst PL, Luo Y, Fang M, Tamir R, Antonio L, Hu
Z, Cupples R, Louis J-C, Hu S, Altrock BW, Fox GM (1996)
GDNF-induced activation of the ret protein tyrosine kinase is me- diated by GDNFR-a, a novel receptor for GDNF. Cell
85:1113–1124.
Kashiba H, Hyon B, Senba E (1998) Glial cell line-derived neurotrophic
factor and nerve growth factor receptor mRNAs are expressed in
distinct subgroups of dorsal root ganglion neurons and are differentially regulated by peripheral axotomy in the rat. Neurosci Lett
252:107–110.
Lazarov-Spiegler O, Solomon AS, Zeev-Brann AB, Hirschberg DL,
Schwartz M (1996) Transplantation of activated macrophages
